Alibaba Health Information Technology Limited (0241.HK) is in Healthcare, Pharmaceutical Retailers, based in Hong Kong, listed on HKSE. Market cap 46.26B HKD. 52-week range 2.75 to 7.91 HKD. Trailing P/E 22.0. Data as of 2026-10-09.
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in the People's Republic of China. It offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. The company also provides medical and ...